Stimulants (e.g., methylphenidate and amphetamine salts) are effective medications for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. This free toolkit is intended to provide an evidence-based guide for thoughtfully converting from one stimulant product formulation to another. The toolkit provides information in the following areas:

Login to Download the Toolkit

  1. General Dosing Considerations
  2. Stimulant Class Comparisons
  3. Stimulant Dose Conversions
  4. Other Important Considerations
  5. References
This toolkit is intended to highlight both the evidence base available as well as strategies of clinical decision making used by expert clinicians. The content reflects the views and practice of the authors as substantiated with evidence-based facts as well as opinion and experience. The opinions and recommendations in this document reflect those of the authors and do not necessarily reflect those of their employers or AAPP.